ONEMEDNET CORPORATION Cash and Restricted Cash
ONEMEDNET CORPORATION (ONMD) had Cash and Restricted Cash of $1.54 thousand as of 2023-09-30, per its 10-Q/A filed 2023-12-18.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2023-12-18
- 2023-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.54K.
- 2023-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.44K.
- 2023-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.11K.
- 2022-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $30.87K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2023-09-30 | $1.54K 10-Q/A · filed 2023-12-18 |
| 2023-06-30 | $3.44K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $10.11K 10-Q · filed 2023-05-19 |
| 2022-12-31 | $30.87K 10-Q/A · filed 2023-12-18 |
| 2022-09-30 | $234.92K 10-Q/A · filed 2023-12-18 |
| 2022-06-30 | $7.48K 10-Q · filed 2023-08-14 |
| 2022-03-31 | $159.13K 10-Q · filed 2023-05-19 |
| 2021-12-31 | $453.15K 10-Q/A · filed 2023-12-18 |
| 2021-09-30 | $533.71K 10-Q · filed 2022-11-18 |
| 2021-06-30 | $802.11K 10-Q · filed 2022-08-15 |
| 2021-03-31 | $25.00K 10-Q · filed 2022-05-16 |
| 2021-02-07 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |